Patients using LloydsPharmacy’s private medicated weight loss service have lost more than 20 tonnes of weight in total since its launch in July 2020, the multiple’s superintendent pharmacist said.
As part of the service, which costs up to £260 a month, eligible patients are offered monthly consultations with a pharmacist, where they are given a Saxenda appetite suppressant (liraglutide; Novo Nordisk).
Saxenda was recommended by the National Institute for Health and Care Excellence in December 2020 for the management of obesity in adults with a body mass index (BMI) greater than 35.
However, the LloydsPharmacy service is open to patients between the ages of 18 and 75, who have a BMI over 30, or a BMI over 27 if they also have a condition made worse by weight gain, such as heart disease.
Around 3,500 patients have used the service since its launch.
In an interview with The Pharmaceutical JournalOn March 16, 2022, Victoria Steele, Superintendent Pharmacist at LloydsPharmacy, said the service “has helped patients lose over 20 tonnes of weight, which is a huge number”.
“So from what was a fairly small service that we rolled out, it had a significant impact on patients,” she said.
LloydsPharmacy later clarified that a total of 23 tonnes of weight was lost by patients between July 2020 and April 2022.
Steele’s comments answered questions about whether the multiple plans to expand the number of private prescribing services he offers, in light of the growing number of pharmacists with independent prescribing qualifications, Steele stating that LloydsPharmacy has “other services that we are currently working on, which are just not ready to be released yet”.
She said the multiple “currently [has] 65 pharmacists holding a clinical degree, which will eventually lead to an independent prescribing qualification (IP).
However, she added that support for pharmacists to use their IP qualifications varies by country.
“It’s clearly very different from country to country, in Wales and Scotland it’s very easy to see your path and the services you will then provide with your qualification,” she said. .
“England still have a bit of a way to go in this area. And then that will help us find our way.
In the interview, Steele also warned that pharmacy’s roles in primary care networks, the ability to become COVID-19 vaccinators, and an increase in early retirement have “chomped” on the workforce. community pharmacy.
“There just aren’t enough pharmacists working in community pharmacies,” she said.
“Some people say, ‘But there are so many people on the register.’ Yes there is. I can’t deny it. Do they work here in community pharmacy? No they are not.”
Pharmacists were added to the Home Office’s shortage occupations list in March 2021, allowing overseas staff to successfully apply for a skilled worker visa through the UK immigration system.